Pricing Log in Create free account

Bioventus Inc. (BVS) vs CeriBell, Inc. (CBLL)

Bioventus Inc. and CeriBell, Inc. are both Medical Devices companies. Bioventus Inc. and CeriBell, Inc. are of similar size ($1.2B and $1.1B). CeriBell, Inc. has negative trailing earnings, so its P/E is not meaningful; Bioventus Inc. trades at 16.4×. CeriBell, Inc. grew revenue faster over the last twelve months: 31.7% against 3.14%. Bioventus Inc. has the higher net margin (9.36% vs −64.7%) and the higher return on invested capital (7.34% vs −229.8%). Across the 17 metrics below, Bioventus Inc. leads on 12 and CeriBell, Inc. on 5.

Valuation

Metric BVS CBLL Medical Devices median
P/E 16.42 n/m 23.22
P/S 1.55 9.34 2.34
P/B 3.25 7.42 2.33
Price to free cash flow 9.57 n/m 23.72
EV/EBITDA 10.83 n/m 11.54
EV/Sales 1.93 8.27 2.24
Earnings yield 6.09% (7.03%) (10.09%)
Free cash flow yield 10.45% (5.89%) (8.47%)

Profitability

Metric BVS CBLL Medical Devices median
Gross margin 68.65% 88.90% 56.01%
Operating margin 10.02% (68.62%) (15.03%)
Net margin 9.36% (64.73%) (20.40%)
Free cash flow margin 16.20% (55.02%) (7.24%)
Return on equity 22.75% (43.93%) (15.32%)
Return on assets 7.89% (35.29%) (19.72%)
Return on invested capital 7.34% (229.76%) (10.33%)

Growth

Metric BVS CBLL Medical Devices median
Revenue growth (TTM) 3.14% 31.70% 8.80%
EPS growth (last fiscal year) 163.46% 56.93% 29.03%
Revenue growth, 5-year CAGR 12.08% — 15.47%
Net income growth, 5-year CAGR 6.73% — 0.00%

Health

Metric BVS CBLL Medical Devices median
Debt to equity 0.90 0.16 0.07
Current ratio 1.69 9.18 2.50
Net debt to EBITDA 2.40 2.38 0.49

Dividend

Metric BVS CBLL Medical Devices median
Dividend yield — — 1.16%
Payout ratio — — 0.36

Size

Metric BVS CBLL Medical Devices median
Market cap 1.16b 1.06b 167.06m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack